COVID-19 Impacts: Antiviral Drugs Market Will Accelerate at a CAGR of Over 9% Through 2020-2024 | Growing Cases of Viral Infections to Boost Growth | Technavio

Source :: Plus Company Updates. August 5, 2020
Publication Year :: 2020
Abstract: LONDON: Technavio Research has issued the following news release: Technavio has been monitoring the antiviral drugs market and it is poised to grow by USD 43.37 billion during 2020-2024, progressing [...]

Subjects :: Merck & Company Inc. -- Forecasts and trends
Johnson & Johnson -- Forecasts and trends
AbbVie Inc. -- Forecasts and trends
Bristol-Myers Squibb Co. -- Forecasts and trends
Gilead Sciences Inc. -- Forecasts and trends
Pfizer Inc. -- Forecasts and trends
Novartis AG -- Forecasts and trends
GlaxoSmithKline PLC -- Forecasts and trends
Sanofi S.A. -- Forecasts and trends
Antiviral agents -- Forecasts and trends -- Health aspects
Pharmaceutical industry -- Forecasts and trends
Biological products industry -- Forecasts and trends
Market trend/market analysis
General interest
News, opinion and commentary

Tools